Literature DB >> 21617226

Association of FOXP3 expression with non-small cell lung cancer.

Fotinos-Ioannis D Dimitrakopoulos1, Helen Papadaki, Anna G Antonacopoulou, Anastasia Kottorou, Andreas D Gotsis, Chrisoula Scopa, Haralabos P Kalofonos, Athanasia Mouzaki.   

Abstract

BACKGROUND/AIM: Lung cancer is rarely cured by current therapeutic approaches. Although numerous studies have implicated FOXP3 positive regulatory T-cells in cancer pathogenesis, the role of FOXP3 in lung cancer pathogenesis remains unkown.
MATERIALS AND METHODS: Using immunohistochemistry FOXP3 expression was determined in 44 NSCLC tissue specimens, 20 samples from adjacent non neoplastic lung parenchyma and 5 normal lung tissue specimens.
RESULTS: FOXP3 immunostaining was always nuclear in both tumor and non-neoplastic adjacent tissues. FOXP3 was also detected at lower levels in normal bronchial epithelium. Moreover, FOXP3 expression in cancer cells correlated with lymphocytic FOXP3-immunopositivity and the presence of lymph node metastasis. FOXP3 lymphocytic expression was also negatively associated with the age of the patients.
CONCLUSION: FOXP3 is overexpressed in NSCLC cells and tumor-infiltrating lymphocytes. This study provides evidence that lymphocytic FOXP3 expression may be age related and that tumor FOXP3 expression is correlated with lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617226

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

1.  IPEX Syndrome, FOXP3 and Cancer.

Authors:  Runhua Liu; Silin Li; Wei-Hsiung Yang; Lizhong Wang
Journal:  J Syndr       Date:  2013-06

2.  FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.

Authors:  Tian Yang; Hong Li; Asmitananda Thakur; Tianjun Chen; Jing Xue; Dan Li; Mingwei Chen
Journal:  Tumour Biol       Date:  2015-05-21

3.  Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung.

Authors:  Akiko Takahashi; Genichiro Ishii; Tomonari Kinoshita; Tatsuya Yoshida; Shigeki Umemura; Tomoyuki Hishida; Kiyotaka Yoh; Seiji Niho; Koichi Goto; Hironobu Ohmatsu; Yuichiro Ohe; Kanji Nagai; Atsushi Ochiai
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-07       Impact factor: 4.553

4.  Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.

Authors:  Anusha-Preethi Ganesan; Magnus Johansson; Brian Ruffell; Adam Yagui-Beltrán; Adam Beltran; Jonathan Lau; David M Jablons; Lisa M Coussens
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

5.  Investigation of FOXP3 genetic variations at positions -2383 C/T and IVS9+459 T/C in southern Iranian patients with lung carcinoma.

Authors:  Maryam Fazelzadeh Haghighi; Mohammad Ali Ghayumi; Farzane Behzadnia; Nasrollah Erfani
Journal:  Iran J Basic Med Sci       Date:  2015-05       Impact factor: 2.699

6.  FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.

Authors:  Shucai Yang; Yi Liu; Ming-Yue Li; Calvin S H Ng; Sheng-Li Yang; Shanshan Wang; Chang Zou; Yujuan Dong; Jing Du; Xiang Long; Li-Zhong Liu; Innes Y P Wan; Tony Mok; Malcolm J Underwood; George G Chen
Journal:  Mol Cancer       Date:  2017-07-17       Impact factor: 27.401

Review 7.  Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.

Authors:  Marlies E Heuvers; Joachim G Aerts; Robin Cornelissen; Harry Groen; Henk C Hoogsteden; Joost P Hegmans
Journal:  BMC Cancer       Date:  2012-12-05       Impact factor: 4.430

8.  Visceral Obesity Promotes Lung Cancer Progression-Toward Resolution of the Obesity Paradox in Lung Cancer.

Authors:  Joseph Barbi; Santosh K Patnaik; Sarabjot Pabla; Robert Zollo; Randall J Smith; Stephanie N Sass; Aravind Srinivasan; Cara Petrucci; Robert Seager; Jeffrey Conroy; Eric Kannisto; Xialong Wang; Shrunjal Shah; Rohit Gosain; Kris Attwood; Charles Roche; Sai Yendamuri
Journal:  J Thorac Oncol       Date:  2021-05-25       Impact factor: 20.121

9.  High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment.

Authors:  G-F Ma; Q Miao; Y-M Liu; H Gao; J-J Lian; Y-N Wang; X-Q Zeng; T-C Luo; L-L Ma; Z-B Shen; Y-H Sun; S-Y Chen
Journal:  Br J Cancer       Date:  2014-02-18       Impact factor: 7.640

10.  Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma.

Authors:  Jing-Jing Song; Si-Jia Zhao; Juan Fang; Da Ma; Xiang-Qi Liu; Xiao-Bing Chen; Yun Wang; Bin Cheng; Zhi Wang
Journal:  BMC Cancer       Date:  2016-07-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.